Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lehmann A et al. – AZD3355 likely inhibits TLESR through stimulation of peripheral GABAB receptors and may offer a potential new approach to treatment of GERD.

Related Articles

Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
Health and Quality of Life Outcomes, 10/22/09    Relevance Score: 89%%

Proton Pump Inhibitors in the Management of GERD
Journal of Gastrointestinal Surgery, 10/01/09    Relevance Score: 89%%

Bronchial hyperreactivity in non-atopic children with asthma and reflux: Effect of anti-reflux treatment
Pediatric Pulmonology, 10/22/09    Relevance Score: 88%%

Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)
Inflammation & Allergy - Drug Targets, 10/12/09    Relevance Score: 88%%

Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care
Alimentary Pharmacology and Therapeutics, 10/26/09    Relevance Score: 87%%

Today in Stomach/GI...keeping you current

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address